Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Veterans Affairs Medical Center - Atlanta (Decatur)
mi
from
Decatur, GA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Veterans Affairs Medical Center - Atlanta (Decatur)
mi
from
Decatur, GA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Saint Anthony's Hospital at Saint Anthony's Health Center
mi
from
Alton, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Saint Anthony's Hospital at Saint Anthony's Health Center
mi
from
Alton, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
St. Joseph Medical Center
mi
from
Bloomington, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Decatur Memorial Hospital Cancer Care Institute
mi
from
Decatur, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Decatur Memorial Hospital Cancer Care Institute
mi
from
Decatur, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
BroMenn Regional Medical Center
mi
from
Normal, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
BroMenn Regional Medical Center
mi
from
Normal, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Community Cancer Center
mi
from
Normal, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Community Cancer Center
mi
from
Normal, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields
mi
from
Olympia Fields, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields
mi
from
Olympia Fields, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
OSF St. Francis Medical Center
mi
from
Peoria, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
OSF St. Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Oncology Hematology Associates of Central Illinois, PC - Peoria
mi
from
Peoria, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Oncology Hematology Associates of Central Illinois, PC - Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Methodist Cancer Center at Methodist Hospital
mi
from
Indianapolis, IN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Methodist Cancer Center at Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Central Indiana Cancer Centers - East
mi
from
Indianapolis, IN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Central Indiana Cancer Centers - East
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
McFarland Clinic, PC
mi
from
Ames, IA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Mercy Cancer Center at Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Mercy Cancer Center at Mercy Medical Center - North Iowa
mi
from
Mason City, IA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
mi
from
Kansas City, KA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Kansas City Cancer Centers - Southwest
mi
from
Overland Park, KA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Kansas City Cancer Centers - Southwest
mi
from
Overland Park, KA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Norton Suburban Hospital
mi
from
Louisville, KY
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Norton Suburban Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
James Graham Brown Cancer Center, University of Louisville
mi
from
Louisville, KY
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
James Graham Brown Cancer Center, University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Greenebaum Cancer Center at University of Maryland Medical Center
mi
from
Baltimore, MD
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Greenebaum Cancer Center at University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Central Maryland Oncology Center
mi
from
Columbia, MD
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Central Maryland Oncology Center
mi
from
Columbia, MD
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Tate Cancer Center at Baltimore Washington Medical Center
mi
from
Glen Burnie, MD
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Tate Cancer Center at Baltimore Washington Medical Center
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Helen P. Denit Cancer Center at Montgomery General Hospital
mi
from
Olney, MD
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Helen P. Denit Cancer Center at Montgomery General Hospital
mi
from
Olney, MD
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Massachusetts General Hospital
mi
from
Boston, MA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Dana-Farber/Brigham and Women's Cancer Center
mi
from
Boston, MA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Dana-Farber/Brigham and Women's Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Boston University Cancer Research Center
mi
from
Boston, MA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Boston University Cancer Research Center
mi
from
Boston, MA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Hudner Oncology Center at Saint Anne's Hospital - Fall River
mi
from
Fall River, MA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Hudner Oncology Center at Saint Anne's Hospital - Fall River
mi
from
Fall River, MA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
MetroWest Medical Center - Framingham Union Hospital
mi
from
Framingham, MA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
MetroWest Medical Center - Framingham Union Hospital
mi
from
Framingham, MA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Lowell General Hospital
mi
from
Lowell, MA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Lowell General Hospital
mi
from
Lowell, MA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Veterans Affairs Medical Center - Ann Arbor
mi
from
Ann Arbor, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Veterans Affairs Medical Center - Ann Arbor
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Josephine Ford Cancer Center at Henry Ford Hospital
mi
from
Detroit, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Josephine Ford Cancer Center at Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Great Lakes Cancer Institute at McLaren Regional Medical Center
mi
from
Flint, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Great Lakes Cancer Institute at McLaren Regional Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Foote Memorial Hospital
mi
from
Jackson, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Foote Memorial Hospital
mi
from
Jackson, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Albert Lea Cancer Center at Albert Lea Medical Center
mi
from
Albert Lea, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Albert Lea Cancer Center at Albert Lea Medical Center
mi
from
Albert Lea, MN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
MeritCare Bemidji
mi
from
Bemidji, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
MeritCare Bemidji
mi
from
Bemidji, MN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Fairview Ridges Hospital
mi
from
Burnsville, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Fairview Ridges Hospital
mi
from
Burnsville, MN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Mercy and Unity Cancer Center at Mercy Hospital
mi
from
Coon Rapids, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Mercy and Unity Cancer Center at Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Duluth Clinic Cancer Center - Duluth
mi
from
Duluth, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Duluth Clinic Cancer Center - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
CCOP - Duluth
mi
from
Duluth, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Miller - Dwan Medical Center
mi
from
Duluth, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Miller - Dwan Medical Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
St. Luke's Hospital Cancer Care Center
mi
from
Duluth, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
St. Luke's Hospital Cancer Care Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Fairview Southdale Hospital
mi
from
Edina, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Fairview Southdale Hospital
mi
from
Edina, MN
Click here to add this to my saved trials